Biologist and PhD in Microbiology at the Institute of Biomedical Sciences of the University of São Paulo. Active in the biochemical and structural characterization of proteins, with experience in the investigation of molecular targets for the development of new drugs against Mycobacterium tuberculosis through Fragment-Based Drug Design (FBDD). Experienced in biophysical and biochemical approaches, such as Thermal Shift, Isothermal Titration Calorimetry (ITC), Nuclear Magnetic Resonance (NMR), X-ray Crystallography, Electronic Cryomicroscopy (Cryo-EM) and enzyme activity and inhibition assays. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Tuberculosis is one of the 10 leading causes of death worldwide and is caused by the agent Mycobacterium tuberculosis. The increasingly recurring emergence of resistant strains of this pathogen motivates researchers around the world and leads to the need for developing new drugs to combat it M. tuberculosis, requiring constant validation of new effective drugs. In this sense, PanK (CoaA) …
| 2 / 2 | Completed scholarships in Brazil |
| Associated processes | |
CV Lattes
ORCID